Professor, MD, chair of DBCG, breast cancer researcher, Aarhus University Hospital, Experimental Clinical Oncology, Danish Centre for Particle Therapy.
Joined May 2019
- Tweets 109
- Following 258
- Followers 531
- Likes 465
8 Photos and videos
Pinned Tweet
22 Jul 2021
Together with my colleague we have recorded a session on target volume delineation in an early breast cancer patient. It’s a one hour session with tips and tricks, link below #estro #breastcancer 🤓👇
estro.org/ESTRO/media/ESTRO/…
1
27
61
18 Dec 2023
Excellent. High-risk pts should be offered RNI incl IMN now. The analysis also shows gain from RNI in node-negative pts and that needs to be discussed. Looking forward🧐
17 Dec 2023
Virtual Grand Rounds in Radiation Oncology
January 10th 17:00 - 17:30 CET
Prof. Carolyn Taylor:
Effect of regional lymph node radiotherapy. An EBCTCG meta-analysis of 14,324 women in 16 trials
Link to Zoom Meeting 👇
usz.ch/veranstaltungen/virtu…
5
26
3,141
Birgitte Offersen retweeted
10 Oct 2023
I am SO excited about this!!! 🤩
We've put together a brilliant (in my humble opinion😉) line-up of speakers to discuss the challenges facing clinical re-irradiation. Please join us, it's going to be so much fun!
#ReIrradiation #medphys #radonc
Join the Reirradiation Webinar Series. Our experts will unravel complexities of #reirradiation throughout 8 sessions, running from Oct 2023 to May 2024.
📅 Save the Date: 1st session kicks off on 26 Oct.
It's FREE!
👉 Programme and Registration: bit.ly/3RZr2ci
#RadOnc
3
19
82
13,097
20 Aug 2023
Agree. RT is postponed for those who need it following a second breast conservation. Most likely a LR in these selected pts does not lead to distant failure. We have now randomised 600 pts in the DBCG Natural trial to - partial breast RT. Heading for 926 pts🧐
Really important study!! We need to avoid over treatment when it doesn't help! @OncoAlert
2
2
6
1,782
4 Jul 2023
Helt enig👍. Lyder for godt til at være sandt, og jeg kan ikke finde Djævelen i detaljen…. Det ser ud til, at de mener det🤩🤓. Super måde at rekruttere, tillykke til dem, som får stillingerne🥂🧐
3 Jul 2023
Det her er altså en RIGTIG god ide @HerlevGentofte‼️ mindst 20% finansieret forskningstid, som led i hoveduddannelsesstilling 💪🏼en god mulighed for karriereudvikling for @YngreLaeger 👏🏼 #forskpol #uddpol #sundpol ➡️ sundhedsjobs.dk/jobopslag/45…
12
789
24 Feb 2023
The figure on the cover is from the editorial—>use the ESTRO guidelines and report your results accordingly🧐. Lift the threshold for RT details when reporting RT from clinical studies: e.g. RT technique, target def., dose/fr, doses to OAR, etc
23 Feb 2023
Vol 179 - just published
ALT Please visit our journal homepages for the full content: https://www.thegreenjournal.com/issue/S0167-8140(22)X0014-5 https://www.sciencedirect.com/journal/radiotherapy-and-oncology/vol/179/suppl/C
5
16
2,677
22 Dec 2022
Radiation associated induration is closely related to irradiated breast volume in the DBCG PBI trial. Validation in the DBCG Hypo trial showed surprising and interesting findings. More info at ESTRO2023 @ESTRO_RT @RadiotherapyOn1
1
9
40
6,342
20 Dec 2022
BIGART is truly a great conference🧐. I am looking forward to the meeting⭐️
1
1
6
1,189
9 Sep 2022
Congratulations to Michael. What an honour to have several doctor titles 🥂🤓⭐️🇩🇰
9 Sep 2022
A good day for radiation oncology and Aarhus University
Professor Michael Baumann DKFZ recieve a honorary doctorate: dr.med honoris causa
Congratulations
1
10
7 Aug 2022
The first results from the DBCG PBI trial support standard use of external beam PBI 40Gy/15fr for selected breast cancer pts. Less morbidity and very few cancer events (not related to PBI). PBI has been DBCG standard since 2016 for low risk BC pts.
Graphs & link below 👇
2
32
73
7 Aug 2022
The pts were minimum 60 yr at randomisation (median 66 yr), and the causes of death were mostly related to non-breast disease.
2
1
9
Birgitte Offersen retweeted
22 Jul 2022
Obsessed with this
12
11
257
6 Apr 2022
Godt gået og meget spændende. Tillykke👍
1
3 Apr 2022
Really interesting results. We need much more focus also on the indication for breast RT, and future trials should be developed based on hypoteses from new results on biology. @TrineTramm #radonc
31 Mar 2022
Out now @JCO_ASCO huge effort of our team and @TILsWorkGroup: Excellent prognosis of TNBC pts with high TILs even without chemo! Chemo de-escalation trials urgently needed! # bcsm ascopubs.org/doi/abs/10.1200…
8
3 Apr 2022
Landsindsamling for Kræftens Bekæmpelse i Risskov i dag. Skønt vejr og mange glade givere. Mere end 60% af beløbet går til forskning.
Forhåbentlig flere kliniske studier til gavn for patienterne @cancer_dk
23
31 Mar 2022
29 Mar 2022
Dr @AskaDrljevic presenting and being awarded her brilliant PhD.
Advanced CT-derived biomarkers in #metastatic #kidney #cancer showing prognostic ability - and #functional #imaging outperforms tumor biopsies in assessing microvessels due to tumor heterogeneity.
1
3